Trends of incidence, mortality and survival of multiple myeloma in Spain. A twenty-three-year population-based study.
D-Y-L Chang-ChanRafael Rios-TamayoM Rodríguez BarrancoD Redondo-SánchezY GonzálezR Marcos-GrageraM J SánchezPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2021)
Incidence remained overall stable throughout the study, with only a small increase for men. Mortality was progressively decreasing in both sexes. Both incidence and mortality were higher in men. Age plays a critical role in survival, with impressive improvement in patients younger than 70 years, but only a minor benefit in those older than 70.